BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36123344)

  • 1. LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.
    Hu J; Huang H; Xi Z; Ma S; Ming J; Dong F; Guo H; Zhang H; Zhao E; Yao G; Yang L; Zhang F; Zheng W; Chen H; Huang T; Li L
    Cell Death Dis; 2022 Sep; 13(9):800. PubMed ID: 36123344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
    Yu H; Wu Y; Huang J; Li S
    Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SEMA3B-AS1 suppresses the tumor-initiating characteristics of triple negative breast cancer via engaging in MLL4-mediated H3K4 trimethylation.
    Chen D; Chen Z; Wang Z; Hong C; Wang Q; Yang P; Huang Z; Lian W; Huang Y; Fu W; Li J; Hong Z
    Mol Carcinog; 2024 Mar; 63(3):371-383. PubMed ID: 37975495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
    Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
    Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway.
    Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S
    Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer.
    Zhang X; Li F; Zhou Y; Mao F; Lin Y; Shen S; Li Y; Zhang S; Sun Q
    Cell Death Dis; 2021 Jun; 12(7):627. PubMed ID: 34145213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
    Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
    Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion effect of FOXCUT as a microRNA sponge for miR-24-3p on progression in triple-negative breast cancer through the p38 MAPK signaling pathway.
    Yu X; Qian F; Zhang X; Zhu Y; He G; Yang J; Wu X; Zhou Y; Shen L; Shi X; Zhang H; Liu X
    Chin Med J (Engl); 2024 Jan; 137(1):105-114. PubMed ID: 38178324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POU2F2-mediated upregulation of lncRNA
    Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
    Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells.
    Zhong Y; Li Y; Song T; Zhang D
    Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer
    Wang Y; Li C
    Comput Math Methods Med; 2022; 2022():8366569. PubMed ID: 35509860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression.
    Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z
    Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
    Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
    Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
    Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
    Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.